Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review

Girijesh Patel, Josiah Perry, Osama Abdul-Rahim, Arthur Frankel, Daniel Cameron, William Taylor, Rodney Rocconi, Laith Abushahin, Cindy Nelson, Ajay Singh, Moh'D Khushman

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review

Fingerprint

Medicine & Life Sciences